本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Orchestra BioMed

4.47
-0.1000-2.19%
盤後4.470.00000.00%16:10 EDT
成交量:9.61萬
成交額:43.04萬
市值:2.62億
市盈率:-4.03
高:4.62
開:4.62
低:4.43
收:4.57
52周最高:5.42
52周最低:2.20
股本:5,852.09萬
流通股本:2,959.41萬
量比:0.79
換手率:0.32%
股息:- -
股息率:- -
每股收益(TTM):-1.1091
每股收益(LYR):-1.1091
淨資產收益率:-109.41%
總資產收益率:-33.90%
市淨率:4.88
市盈率(LYR):-4.03

資料載入中...

2025/02/05

重要事件披露

Form 8-K - Current report
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

重要事件披露

Form 8-K - Current report
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/07

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/30

重要事件披露

Form 8-K - Current report
2024/07/17

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/23

SEC問詢函

Form CORRESP - Correspondence
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]